A randomized, controlled, repeat-dose study of batefenterol/fluticasone furoate compared with placebo in the treatment of COPD.
Courtney CrimMark GotfriedSelwyn SpangenthalMichael WatkinsAmanda EmmettCatriona CrawfordCharlotte BaidooRamiro Castro-SantamariaPublished in: BMC pulmonary medicine (2020)
Clinicaltrials.gov: NCT02573870 (submitted October 12, 2015).